Cachexia is a metabolic syndrome associated with underlying illnesses such as cancer and is characterized by the loss of muscle with or without loss of fat mass. It is estimated that half of all patients with cancer eventually develop cachexia. This condition deteriorates the outlook for cancer patients and therefore has to be addressed as part of the overall treatment. To stop cancer from growing is the best strategy to reverse cachexia but here are some additional options:
- Ammonia π can contribute to muscle wasting regardless of the cause of its increased levels {ref}. There is a direct link between hyperammonemia and increased myostatin expression.→ remove ammonia, and improve ammonia elimination.
- Rikkunshito, also called Liu jun zi tang: has been shown to have significant clinical benefits for cachexia. {study}
- MYO X (contains active follistatin)
- Vitamin D3 + Magnesium + K2 (100mcg K2 per 10,000 IU D3)
- Bovine Tracheal Cartilage
- Cat’s Claw
- Vitamin C {Ref}
- Garlic
- Curcumin + Rutin
- Carnitine {ref}, Creatine, Leucine and Vitamin D
- Ursolic acid {study}
- Tomatidine
- Ginger and Licorice {study}
- Cannabigerol
- Eat enough fiber (fruit and vegetables)
- Magnolol {ref}
- Shark liver oil
- Vitamin B3 {ref}
References & Sources
- Role of Activin A and Myostatin in Human Cancer Cachexia
- The Structure of the Follistatin: Activin Complex Reveals Antagonism of Both Type I and Type II Receptor Binding
- https://www.ncbi.nlm.nih.gov/pubmed/19393114
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4398892/
- https://cosmosmagazine.com/biology/how-stop-cancer-patients-wasting-away
- http://www.nature.com/news/cachexia-the-last-illness-1.18961
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3623008/
- https://www.ncbi.nlm.nih.gov/pubmed/24759931
- http://www.anticancerbook.com/post/The-best-way-to-fight-weight-loss-linked-to-illness.html
- Citrate:https://www.cancertreatmentsresearch.com/citric-acid-inhibits-fermentation-and-kills-cancer-in-humans/#comment-8985
- Cachexia and Wasting: A Modern Approach
.jpeg)
.png)
No comments:
Post a Comment